Format

Send to

Choose Destination
J Endocr Soc. 2017 Feb 1;1(2):113-123. doi: 10.1210/js.2016-1085. Epub 2017 Jan 13.

Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women.

Author information

1
Center for Lipid Metabolomics, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
2
Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
3
Center for Clinical and Epidemiologic Research, Hospital Universitario, University of Sao Paulo, Sao Paulo, Brazil.
4
Harvard T. H. Chan School of Public Health, Boston, MA.
5
Canyons Medical Center, Sandy, UT.
6
VAP Diagnostics Laboratory, Birmingham, AL.

Abstract

CONTEXT:

Whether subclinical hypothyroidism (SCH) is associated with cardiometabolic abnormalities is uncertain.

OBJECTIVE:

To examine diverse cardiometabolic biomarkers across euthyroid, SCH, and overt hypothyroidism (HT) in women free of cardiovascular disease (CVD).

DESIGN:

Cross-sectional adjusted associations for lipids, lipoprotein subclasses, lipoprotein insulin resistance score, inflammatory, coagulation, and glycemic biomarkers by ANCOVA for thyroid categories or TSH quintiles on a Women's Health Study subcohort.

SETTING:

Outpatient.

PATIENTS OR OTHER PARTICIPANTS:

Randomly sampled 3,914 middle-aged and older women for thyroid function analysis (thyroid-stimulating hormone [TSH], free T4), of whom 3,321 were not on lipid lowering therapy.

INTERVENTION:

None.

MAIN OUTCOME MEASURE:

Associations of SCH and HT with cardiometabolic markers.

RESULTS:

Going from euthyroid to HT, the lipoprotein subclasse profiles were indicative of insulin resistance [respective values and p for trend]: larger VLDL size (nm)[51.5 (95%CI51.2, 51.8) to 52.9 (51.8, 54.1) p=0.001]; higher LDL particles concentration (nmol/L)[1283 (95%CI1267, 1299) to 1358 (1298, 1418) p=0.004] and smaller LDL size. There was worsening lipoprotein insulin resistance score from euthyroid 49.2 (95%CI 48.3, 50.2) to SCH 52.1 (95%CI 50.1, 54.0), and HT 52.1 (95%CI 48.6, 55.6), p for trend 0.008. Of the other biomarkers, SCH and HT were associated with higher hs-CRP and HbA1c. For increasing TSH quintiles results were overall similar.

CONCLUSIONS:

In apparently healthy women, SCH cardiometabolic profiles indicated worsening insulin resistance and higher CVD risk markers compared with euthyroid individuals, despite similar LDL and total cholesterol. These findings suggest that cardiometabolic risk may increase early in the progression towards SCH and OH.

KEYWORDS:

Coagulation; Inflammation; Insulin Resistance; Lipoproteins; Metabolomics; Subclinical Hypothyroidism

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center